Archive for the ‘Endocrinology’ Category

Skin-Lightening Cremes Sold On Black Market Have Serious Health Risks

Wednesday, February 20th, 2008

A Clinical Picture described in the February 16, 2008 issue of The Lancet underlines the perils of using skin lightening creams sold on the black market. Dr. Tricia Tan and Dr. Tony Goldstone of the Endrocrine Unit in the Department of Investigative Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, ...

Skin-Lightening Cremes Sold On Black Market Have Serious Health Risks

Wednesday, February 20th, 2008

A Clinical Picture described in the February 16, 2008 issue of The Lancet underlines the perils of using skin lightening creams sold on the black market. Dr. Tricia Tan and Dr. Tony Goldstone of the Endrocrine Unit in the Department of Investigative Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, ...

ASCO GU 2008 - Metabolic Syndrome In America: Implications For Treatment

Monday, February 18th, 2008

UroToday.com - Dr. Freedland discussed the metabolic syndrome that is a combination of medical disorders that increases one's risk for cardiovascular (CV) disease. It is defined by 3 of 5 criteria; waist circumference >102cm, high triglycerides or HDL, glucose intolerance or high BP. The metabolic syndrome increases the CV risk ...

ASCO GU 2008 - Metabolic Syndrome In America: Implications For Treatment

Sunday, February 17th, 2008

UroToday.com - Dr. Freedland discussed the metabolic syndrome that is a combination of medical disorders that increases one's risk for cardiovascular (CV) disease. It is defined by 3 of 5 criteria; waist circumference >102cm, high triglycerides or HDL, glucose intolerance or high BP. The metabolic syndrome increases the CV risk ...

Hormone Therapy In Early Post Menopause Has No Effect On Memory

Tuesday, September 25th, 2007

Hormone therapy taken in the first few years after menopause does not appear to affect a woman's memory, but may lead to increased sexual interest, according to a study published in the September 25, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology. The study, the largest ...

Study Published In Endocrinology Reports Potential Of Modigene Technology To Extend Duration Of Protein Drugs

Tuesday, September 25th, 2007

Modigene Inc. (OTC Bulletin Board: MODG) reported that researchers will publish a study in the October edition of the journal Endocrinology showing that erythropoietin (EPO) linked to Modigene's carboxyl terminal peptide (CTP) technology significantly increased the half-life of standard EPO in animal models.(1) ...

Callisto Pharmaceuticals Completes Enrollment Of Phase II Trial Of Atiprimod In Neuroendocrine Cancer

Friday, September 21st, 2007

Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases, announced that complete enrollment of its Phase II clinical trial of Atiprimod to treat low to intermediate grade neuroendocrine carcinoma (advanced ...

Breast Growth In Men Surprisingly Common

Thursday, September 20th, 2007

Breast growth in men is surprisingly common, and affects between 40 and 50 per cent of men at some point in their lives. Gynecomastia, or the benign enlargement of breast tissue, is common in teenage males as well as middle aged and older men. A clinical practice article on gynecomastia, using ...

Hyperthyroidism And Goiter

Tuesday, August 14th, 2007

The thyroid gland has an important role in determining how much energy the body burns. Thyroid gland functions are regulated by a hormone known as thyroid-stimulating hormone (TSH). Increased levels of TSH, as well as increased signaling through the receptor for TSH, result in hyperthyroidism (characterized by weight loss because ...